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Insecticide-based interventions have contributed to ∼78% of the
reduction in the malaria burden in sub-Saharan Africa since 2000.
Insecticide resistance in malaria vectors could presage a catastrophic
rebound in disease incidence and mortality. A major impediment to
the implementation of insecticide resistance management strate-
gies is that evidence of the impact of resistance on malaria disease
burden is limited. A cluster randomized trial was conducted in
Sudan with pyrethroid-resistant and carbamate-susceptible malaria
vectors. Clusters were randomly allocated to receive either long-
lasting insecticidal nets (LLINs) alone or LLINs in combination with
indoor residual spraying (IRS) with a pyrethroid (deltamethrin) in-
secticide in the first year and a carbamate (bendiocarb) insecticide in
the two subsequent years. Malaria incidence was monitored for 3 y
through active case detection in cohorts of children aged 1 to<10 y.
When deltamethrin was used for IRS, incidence rates in the LLIN +
IRS arm and the LLIN-only arm were similar, with the IRS providing
no additional protection [incidence rate ratio (IRR) = 1.0 (95% con-
fidence interval [CI]: 0.36–3.0; P= 0.96)]. When bendiocarb was used
for IRS, there was some evidence of additional protection [interac-
tion IRR = 0.55 (95% CI: 0.40–0.76; P < 0.001)]. In conclusion, pyre-
throid resistance may have had an impact on pyrethroid-based IRS.
The study was not designed to assess whether resistance had an
impact on LLINs. These data alone should not be used as the basis
for any policy change in vector control interventions.
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To date, the 21st century has seen an unprecedented reductionin the global burden of malaria. While still unacceptably high,
disease incidence in sub-Saharan Africa has decreased by 42%
from an average of 427 cases per 1,000 persons at risk in 2,000 to
246 cases per 1,000 persons at risk in 2015; infection prevalence
with Plasmodium falciparum in children aged 2–10 y has halved
from 33 to 16% over the same period (1). This has resulted in an
estimated 1.2 billion fewer malaria cases and 6.2 million fewer
malaria deaths. Recent estimates show that the widespread de-
ployment of insecticide-based interventions has been, over-
whelmingly, the driver of the reduction in malaria in Africa (2).
Of the 663 million clinical cases estimated to have been averted
due to malaria control interventions since 2000, 78% were at-
tributable to insecticide-treated nets or indoor residual spraying
(IRS). These two interventions have been massively scaled up
since 2000 (1).
Emerging insecticide resistance in the anopheline malaria
vectors could presage a catastrophic rebound in disease in-
cidence. At present, there are only four insecticide classes avail-
able to malaria control programs; pyrethroids, organochlorines,
carbamates, and organophosphates, with pyrethroids being the
only class currently recommended by the WHO for use on long-
lasting insecticidal nets (LLINs). Pyrethroids and the organo-
chlorine dichlorodiphenyltrichloroethane (DDT) share the same
target site, the voltage-gated sodium channel, while carbamates
and organophosphates are acetylcholinesterase inhibitors. Re-
sistance to pyrethroids is extensive throughout sub-Saharan Africa,
while resistance to the three nonpyrethroid chemical classes used
for IRS is simultaneously emerging in many regions (3–5). Re-
sistance arises mainly from a combination of mutations within
mosquitoes at the target site of the insecticide and enhanced de-
toxification/excretion of the insecticide.
While conclusive evidence that resistance is directly impacting
epidemiological indicators of malaria is scanty, by the time such
data are available, it may well be too late. To address the
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problem, the WHO developed the Global Plan for Insecticide
Resistance Management in malaria vectors (GPIRM), which was
designed to forestall a disastrous increase in malaria burden (6).
Unfortunately, most malarious countries have yet to amend their
vector control strategies to align with the GPIRM despite wide-
spread resistance to pyrethroids (7). While this is partially due to
the absence of compelling data on the impact of insecticide re-
sistance, it also reflects the lack of viable alternatives to LLINs and
current insecticides.
A five-country study was established to provide quantitative
estimates of the impact of resistance on malaria burden (8). One
study was conducted in Galabat, Sudan. In Sudan, almost the
entire population lives in areas with low to moderate transmission.
Malaria transmission is seasonal and unstable. Countrywide, the
majority of the population (80%), including urban populations,
live in areas with <1% P. falciparum infection risk in children aged
2–10 y, while the remaining 20% of the population, residing
mainly in the south of the country, experience meso- to hyper-
endemic risk of infection (9). Reported malaria cases were re-
duced from an estimated 7.5 million in 1990 (10) to 1.2 million in
2014. P. falciparum accounts for 95% of the malaria burden (9,
10), with Anopheles arabiensis being the main malaria vector (11).
In Sudan, artemisinin-based combination therapy has been
used for malaria treatment since 2004, with artesunate plus
sulfadoxine/pyrimethamine as first-line treatment, artemether/
lumefantrine as second-line therapy, and quinine for the treat-
ment of complicated malaria (10). Malaria diagnosis is based on
microscopy and rapid diagnostic tests (RDTs) (10). Between
2013 and 2015, 13 million LLINs were distributed, resulting
in overall coverage of 92% of households with one LLIN per
two persons in 2015 according to Ministry of Health reports.
Therefore, the emergence of insecticide resistance (12, 13) is a
major concern as it could severely compromise the effectiveness
of vector control in Sudan.
Galabat, Gedarif State, was considered suitable for this study
since malaria is highly seasonal and more intense there than in
many other parts of Sudan, and it had no previous history of IRS.
Human settlements also facilitate the formation of well-separated
clusters. Twenty-six villages were selected as study clusters and
received universal coverage of LLINs. Thirteen of these clusters
were randomly selected to receive IRS in addition to LLINs. In
2012, deltamethrin was used for IRS, which was replaced by
bendiocarb in 2013 and 2014. The protective effect of bendiocarb,
to which there was no resistance, could therefore be compared
with the effect of deltamethrin, to which there was insecticide
resistance, with the LLIN-only clusters acting as controls. For
ethical reasons, it was not feasible to assess the impact of in-
secticide resistance on the overall effectiveness of LLINs since this
would require a neutral arm with no vector control.
This study aimed to quantify:
i) The impact of switching to a nonpyrethroid IRS insecticide
on the incidence and prevalence of malaria infection in an
area of moderate pyrethroid resistance
ii) The impact of phenotypic and genotypic insecticide resis-
tance on the incidence and prevalence of malaria infection
iii) The impact of the addition of nonpyrethroid IRS insecticide
on the evolution of pyrethroid resistance in an area of uni-
versal LLIN coverage
iv) The cost of using nonpyrethoid IRS in addition to LLIN
coverage to mitigate the negative consequences of pyre-
throid resistance on the incidence of malaria infection
Results
Intervention Coverage. Following a census to determine the
number of households and population size of the study area,
72,714 LLINs (PermaNet 2.0; Vestergaard) were distributed in
the 26 clusters in April 2011 to protect 139,566 individuals based
upon a universal coverage approach of one net for two people.
Nets were replaced in June 2014 with 72,098 new LLINs for
122,647 people. An annual intervention assessment survey
showed that household net ownership was 99.6% in 2012, 82.1%
in 2013, and 98.6% in 2014. LLIN usage, defined as the pro-
portion of affirmative responses to the question “Did this child
sleep under an LLIN last night?”, was generally high and very
similar in study arms (Table 1), but varied by season throughout
the year (data not tabulated). IRS was conducted in August and
again in late December of each year. In 2012, both spray rounds
utilized deltamethrin (25 mg of active ingredient per square
meter; Chema Industries), while in 2013 and 2014, bendiocarb
(Ficam 80% WP; Bayer; 200 mg of active ingredient per square
meter) was sprayed. IRS spray coverage was 99%, 82%, and 83%
in the years 2012, 2013, and 2014, respectively, as determined by
annual cross-sectional surveys. The IRS coverage reported in the
LLIN arm is from the householder questionnaires. It is possible
that this was from private spraying, but more likely that it rep-
resents householder misreporting.
During the 3-y period from June 1, 2012–May 31, 2015, there
were 643 episodes of malaria in 7,529 cohort children who were
followed up cumulatively for 17,284 person-years. The mean age
of cohort children was similar in the two study arms in each year,
but rose gradually from 5.2 y in the first study year to 6.25 y in the
third year (Table 1).
Incidence of Malaria and Prevalence of Malaria Infection by Study
Arm and by IRS Insecticide. Mean overall incidence was 37.2 per
1,000 person-years [95% confidence interval (CI): 24.3–56.9],
declining from 49.9 per 1,000 person-years in year 1, to 36.1 per
1,000 person-years in year 2, to 26.8 per 1,000 person-years in
year 3.
Mean incidence in the LLIN + IRS study arm was 47.2 per
1,000 person-years when deltamethrin was used (2012), but was
almost halved to an average of 24.6 per 1,000 person-years
during the 2 y when bendiocarb was used (2013 and 2014) (Ta-
ble 2). Over the same period in the LLIN-only arm, incidence
remained virtually unchanged, from 44.4 per 1,000 person-years
in year 1 to 42.1 per 1,000 person-years in years 2–3. Comparing
incidence between study arms, the incidence rate ratio (IRR) for
LLIN + deltamethrin compared with LLIN alone (2012) was 1.0
(95% CI: 0.36–2.97; P = 0.96); for LLIN + bendiocarb versus
LLINs alone (2013), it was 0.60 (95% CI: 0.39–0.91; P = 0.017),
while for 2014 (LLIN + bendiocarb versus LLIN), it was 0.69
(95% CI: 0.31–1.50; P = 0.35). For the two bendiocarb years
combined, the IRR for IRS + LLIN versus. LLIN alone was 0.65
(95% CI: 0.44–0.96; P = 0.032). There was strong evidence that
the change in insecticide modified the effect of IRS + LLIN
versus LLIN alone: The IRR for comparing the effect of IRS +
LLIN in 2013 and 2014 (bendiocarb) versus LLIN alone with the
effect of IRS + LLIN in 2012 (deltamethrin) versus LLIN alone
was 0.51 (95% CI: 0.35–0.73; P < 0.001) and 0.62 (95% CI: 0.42–
0.93; P = 0.020), respectively (overall interaction P = 0.001;
Table 2). The interaction IRR comparing the effect of IRS +
LLIN in 2013–2014 combined (bendiocarb) versus LLIN alone
with the effect of IRS + LLIN in 2012 (deltamethrin) versus
LLIN alone was 0.55 (95% CI: 0.40–0.76; P < 0.001).
In a sensitivity analysis to test the robustness of the results to
the possibility of undue influence exerted by participants who had
multiple episodes of malaria, follow-up was restricted to the
550 first episodes observed (i.e., censoring follow-up after the first
positive test result). This analysis produced very similar findings to
those obtained from the full dataset (results not tabulated).
In the three cross-sectional prevalence surveys that were
conducted from September to October of each of the three study
years, 2,518, 3,445, and 3,841 children were tested by RDTs, of
whom 214 (8.5%), 146 (4.2%), and 162 (4.2%) tested positive
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in 2012, 2013, and 2014, respectively. Analogous results were
recorded to those comparing malaria incidence (Table 3). In the
IRS + LLIN study arm, mean prevalence of infection fell from
10.4% when deltamethrin was used for IRS (2012) to 3.4% when
bendiocarb was used (years 2013/2014) (P = 0.002). Over the
same period, mean prevalence in the LLIN-only arm declined
more moderately and nonsignificantly from 6.7 to 5.0% (P =
0.41). Comparing prevalence between study arms, the odds ratio
(OR) for LLIN + deltamethrin versus LLIN alone in 2012 was
2.11 (95% CI: 0.36–2.97; P = 0.96); for LLIN + bendiocarb
versus LLINs alone (2013), it was 1.39 (95% CI: 0.32–6.14; P =
0.66), while for 2014, it was 0.37 (95% CI: 0.18–0.77; P = 0.007).
For the two bendiocarb years combined, the OR for LLIN + IRS
versus LLIN alone was 0.61 (95% CI: 0.29–1.27; P = 0.19). There
was strong evidence that the change in insecticide modified the
effect of IRS with an overall interaction of P = 0.001 for in-
teraction tests applied to individual years (left-hand side of Table
3) and P < 0.001 for interaction tests applied to 2012 versus
2013/2014 combined (right-hand side of Table 3). The in-
teraction OR for comparing the effect of IRS + LLIN in
2013 and 2014 (bendiocarb years) versus LLIN alone with the
effect of IRS + LLIN in 2012 (deltamethrin) with LLIN alone
was 0.55 (95% CI: 0.35–0.87; P = 0.01) and 0.30 (95% CI: 0.19–
0.47; P < 0.001), respectively. The interaction OR comparing the
effect of IRS + LLIN in 2013–2014 combined (versus LLIN
alone) with the effect of IRS + LLIN in 2012 (deltamethrin)
(versus LLIN alone) was 0.40 (95% CI: 0.27–0.59; P < 0.001).
Association Between Resistance and Incidence and Prevalence of
Malaria Infection. During the course of the study, 4,680 female
An. arabiensis mosquitoes were phenotyped for deltamethrin
susceptibility using WHO discriminating dose tests (14), with
evidence of resistance to deltamethrin in both study arms (Fig.
1). The mean percentage mortality in the LLIN arm (65.0%,
95% CI: 44.6–85.3) was not significantly different (t = 0.425; df,
9; P = 0.68) from that of the LLIN + IRS arm (60%, 95% CI:
38.2–82.2) during year 1. The assay for the Vgsc-1014F mutation
was successfully conducted in 1,847 of 1,872 specimens (Fig. 1).
There was a subsequent decrease in allelic frequency (two-way
ANOVA, P < 0.001), but no evidence of an association between
allelic frequency and the study arm (two-way ANOVA, P > 0.05;
Fig. 1). There was no evidence of nonnormality of the mortality
or the allele frequency data.
The association between cluster- and year-specific bioassay
survivorship (phenotypic resistance) and cluster- and year-specific
malaria incidence in cohort children was assessed using multiple
Table 1. LLIN usage, IRS coverage, insecticide resistance, prevalence of infection, and malaria incidence in cohort children by study arm
and study year
LLIN-only arm LLIN + IRS arm
Variable 2012 2013 2014 2012 2013 2014
LLIN usage, %
(child nights)
79 (73,375) 74 (75,040) 82 (78,918) 79 (73,738) 75 (74,612) 82 (78,888)
IRS coverage, % (N) 9 [1–45] (1,320) 1 [0–2] (1,954) 4 [1–27] (2,195) 99 [96–100] (1,314) 82 [75–87] (1,816) 83 [68–91] (2,032)
Mean age, y 5.1 [4.9–5.4] 5.4 [5.2–5.5] 6.2 [6.1–6.3] 5.2 [5.0–5.4] 5.5 [5.4–5.7] 6.3 [6.1–6.4]
Malaria cases 117 155 98 126 82 65
Malaria incidence* 45 [24–87] 52 [26–101] 33 [14–78] 47 [20–110] 27 [15–50] 21 [10–43]
Prevalence of infection,
% (N)
7 [3–14] (1,272) 5 [2–10] (1,791) 5 [3–9] (1,961) 10 [6–16] (1,246) 4 [2–7] (1,654) 3 [2–5] (1,880)
Deltamethrin mortality
(clusters), % (references)
65 [49–81] (6) 90 [85–95] (6) 56 [48–64] (11) 60 [44–76] (5) 84 [71–96] (6) 68 [61–75] (13)
95% CIs are shown in brackets.
*Cases per 1,000 child-years.
Table 2. Effect of year, study arm, and IRS insecticide on malaria incidence, Galabat, Sudan, 2012–2014
Effects by individual study years
Effects comparing 2013/2014 (bendiocarb) with 2012
(deltamethrin)
Year
Study
arm Cases
Mean
incidence
(range)
Unadjusted
rate ratio
(95% CI)
Adjusted
rate ratio*,
(95% CI)†
Bendiocarb
effect‡ Period
Study
arm
Mean
incidence
Adjusted
rate ratio*,
(95% CI)‡
Bendiocarb
effect‡
2012 LLIN 117 45 (24–87) 1 1 1 2012 LLIN 45 (4–87) 1
LLIN + Delta 126 47 (20–110) 1.0
(0.36–2.95);
P = 0.96
1.0
(0.36–2.97);
P = 0.96
LLIN + Delta 47 (20–110) 1.0
(0.36–2.97);
P = 0.96
1
2013 LLIN 155 52 (26–101) 1 1 0.51
(0.35–0.73);
P < 0.001
2013/2014 LLIN 42 (21–85) 1
LLIN + Bend 82 27 (15–50) 0.53
(0.21–1.32);
P = 0.17
0.60
(0.39–0.91);
P = 0.017
2014 LLIN 98 33 (14–78) 1 1 0.62
(0.42–0.93);
P = 0.020
LLIN + Bend 25 (13–47) 0.65
(0.44–0.96);
P = 0.032
0.55
(0.40–0.76);
P < 0.001
LLIN + Bend 65 21 (10–43) 0.62
(0.20–1.95);
P = 0.42
0.69
(0.31–1.50);
P = 0.347
*Adjusted for age at time of visit and, for 2013 and 2014, the rate in 2012.
†Test to determine if the effect of IRS was different between years (P = 0.001).
‡Test comparing the effect of bendiocarb IRS and deltamethrin IRS (P < 0.001).
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variable Poisson regression models, adjusting for study arm and
study year. Unadjusted and adjusted IRRs show no association
between malaria incidence in cohort children and deltamethrin
bioassay survivorship in mosquitoes from corresponding clusters
(Fig. 2 and Table 4). To estimate any effect that resistance in a
particular year and a particular cluster may have had on the
prevalence of infection as determined by annual cross-sectional
surveys, logistic regression was carried out, again adjusting for
study arm and study year. Unadjusted and adjusted ORs showed
no evidence of any association between resistance as measured
through bioassay survivorship and infection prevalence (Table 3).
Similar analysis was carried out to investigate whether malaria
incidence and infection prevalence were associated with Vgsc-
1014F frequency, measured in mosquito specimens collected in
corresponding clusters and years. There was no evidence of any
association between malaria incidence or infection prevalence
on the one hand and Vgsc-1014F frequency on the other (Fig. 2
and Table 4).
Subgroup analysis was carried out restricted to the combined
data from the LLIN-only arm for all 3 y and to the LLIN + IRS
arm for the year in which deltamethrin was sprayed. There was
again no association between malaria incidence and Vgsc-1014F
frequency (P = 0.59), between infection prevalence and Vgsc-
1014F frequency (P = 0.39), between malaria incidence and
bioassay survivorship (P = 0.85), and between infection preva-
lence and bioassay survivorship (P = 0.98).
Association Between the Addition of Nonpyrethroid IRS Insecticide
and the Evolution of Insecticide Resistance to Pyrethroids in an Area
of Universal LLIN Coverage. It was only possible to conduct re-
sistance phenotyping in 11 and 12 clusters in 2012 and 2013,
respectively; this figure rose to 24 in 2014. In 2012 as well as in
2013 (the first year of bendiocarb spraying), there was no signifi-
cant difference in mosquito deltamethrin susceptibility between
intervention arms. However, in 2014, there was significantly higher
mortality (less resistance) in the LLIN + IRS arm (n = 13; mor-
tality = 68%; 95% CI: 60–76) compared with the LLIN arm (n =
11; mortality = 56%; 95% CI: 47–65) (P = 0.038) (Fig. 1). In all
clusters across all years, An. arabiensis populations were suscep-
tible to bendiocarb.
Cost and Cost-Effectiveness. The cost of protection with LLIN
only in Galabat was estimated to be US $2.16 per person-year,
Table 3. Effect of year, study arm, and IRS insecticide on malaria prevalence, Galabat, Sudan, 2012–2014
Effects by individual study years Effects comparing 2013/2014 (bendiocarb) with 2012 (deltamethrin)
Year
Study
arm
Prevalence,
% (N)
Unadjusted
OR Adjusted OR*
Bendiocarb
effect† Period
Study
arm
Mean
prevalence, %
Adjusted
OR*
Bendiocarb
effect‡
2012 LLIN 7 [3–14]
(1,272)
1 1 2012 Delta LLIN 7 [3–14]
(1,272)
1
LLIN + IRS 10 [6–16]
(1,246)
1.61
[0.60–4.35];
P = 0.33
2.11
[0.85–5.22];
P = 0.11
LLIN + IRS 10 [6–16]
(1,246)
2.11
[0.85–5.22];
P = 0.11
1
2013 LLIN 5 [2–10]
(1,791]
1 1 2013–2014
Bendiocarb
LLIN 5 [2.8–8.6]
(3,752)
1
LLIN + IRS 4 [2–7]
(1,654)
0.86
[0.31–2.42];
P = 0.77
1.39
[0.32–6.14];
P = 0.66
0.55
[0.35–0.87];
P = 0.01
2014 LLIN 5 [3–9]
(1,961)
1 1 LLIN +I RS 3.4 [2.1–5.4]
(3,534)
0.61
[0.29–1.27];
P = 0.19
0.40
[0.27–0.59];
P < 0.001
LLIN + IRS 3 [2–5]
(1,880)
0.54
[0.26–1.13];
P = 0.098
0.37
[0.18–0.77];
P = 0.007
0.30
[0.19–0.47];
P < 0.001
95% CIs are shown in brackets. Delta, deltamethrin.
*Adjusted for age, study arm, and study period.
†Overall likelihood ratio test, P < 0.0001 (test to determine if effect of IRS was different between years).
‡Overall likelihood ratio test, P < 0.0001 (test comparing the effect of bendiocarb IRS and deltamethrin IRS).
Fig. 1. Change in deltamethrin mortality (Upper) and Vgsc-1014F (Lower)
across study years and between single (LLIN) and dual (LLIN + IRS) intervention
arms. Box whisker plots show the median (bold line) and interquartile range
(boxes). Phenotypic data were available from six LLIN and five LLIN + IRS clusters
in 2012, six LLIN and six LLIN + IRS clusters in 2013, and 11 LLIN and 13 LLIN + IRS
clusters in 2014. Genotypic data were available for all 26 clusters for all years. In
2014, there was significantly (P = 0.038) higher mortality (less resistance) in the
LLIN + IRS arm (n = 13; mortality = 68%; 95% CI: 60.0–76.0) compared with the
LLIN-only arm (n = 11; mortality = 56.1%; 95% CI: 47.1–64.9).
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while the cost of protection per person-year with LLIN + IRS
(deltamethrin) was estimated to be US $4.36. The cost per person-
year of protection with LLIN + IRS (bendiocarb) was estimated
to be US $5.01. These cost estimates translate into an incre-
mental cost of switching from IRS with deltamethrin to IRS with
bendiocarb in this study of US $0.65 per person-year. With the
year 1 incidence of 49.9 episodes per 1,000 person-years, this
translates to an incremental cost per case averted of US $29.
Assuming a case fatality rate for malaria of 0.005, the incre-
mental cost per death averted was approximately US $6,400 and
an incremental cost per disability adjusted life year (DALY)
averted of US $195. These results are well within accepted
standards for highly cost-effective interventions for Sudan
established by the WHO (15). Sensitivity analysis indicated that
changes to discount rate, prices of LLINs, or allocation of shared
costs did not affect the incremental costs of the insecticide switch
and that reduction of the cost of bendiocarb to the cost of del-
tamethrin would have resulted in nearly identical costs per person
protected, indicating that there were only minor differences in
delivery costs for the intervention with bendiocarb. Sudan is an
area with low malaria incidence, and it is likely that in other areas
with a higher incidence and more severe pyrethroid resistance,
such a switch is likely to be associated with even greater cost-
effectiveness.
Discussion
Association Between Malaria Incidence/Prevalence and Switching
Active Ingredients. Malaria incidence was similar and malaria
prevalence was higher in the study arm in which deltamethrin
IRS was sprayed in addition to LLIN use, compared with LLINs
alone. The higher prevalence in the LLIN + IRS arm was likely
to be the result of an imperfect balance in the two study arms. In
the following 2 y when IRS with bendiocarb replaced delta-
methrin, there was a significant reduction in the LLIN + IRS
arm compared with the year in which deltamethrin was used,
while incidence and prevalence remained stable in the clusters
that only had LLINs. Compared with the LLIN-only arm, in-
cidence was significantly lower in the IRS + LLIN arm in the 2 y
in which bendiocarb was used [IRR = 0.65 (95% CI: 0.44–0.96;
P = 0.032)], and this effect differed significantly from the effect
of IRS + LLIN with deltamethrin [interaction IRR = 0.55 (95%
CI: 0.40–0.76; P < 0.001)]. Prevalence of infection was only lower
in the IRS + LLIN arm compared with the LLIN-only arm of the
study in 2014; however, again, there was very strong evidence
that bendiocarb significantly modified the effect of IRS when
comparing the OR between study arms during the years in which
bendiocarb was used with the OR between study arms when
deltamethrin was used [interaction OR = 0.40 (95% CI: 0.27–
0.59; P < 0.001)]. Deltamethrin has been shown to be effective
when used for IRS in a variety of settings (16–19). While we
cannot completely discount differential longevity of the delta-
methrin and bendiocarb IRS formulations used in Sudan, the
expectation from previous studies is that the deltamethrin for-
mulation would have a marginally longer residual life than the
bendiocarb formulation. We conclude that the presence of py-
rethroid resistance is a plausible explanation for the loss of effec-
tiveness of deltamethrin IRS, resulting in substantially suboptimal
malaria control. To date, there are few studies assessing the impact
of insecticide resistance as the design of such studies is problematic
because (i) the exposure of interest, resistance to an insecticide in
the local vector, cannot be randomly allocated and (ii) it is un-
ethical to knowingly protect a human population with IRS using an
insecticide that is unlikely to be effective if alternatives are avail-
able. Evidence of the impact of insecticide resistance on IRS has
thus far always been generated by retrospective studies (20, 21).
Our data, when considered with two retrospective studies from South
Africa and Uganda, where the primary vectors were Anopheles
funestus and Anopheles gambiae, respectively, provide further
evidence that pyrethroid resistance is highly likely to be compro-
mising the effectiveness of IRS.
The impact of resistance in KwaZulu-Natal, South Africa, was
more marked than that observed in the current study, with a near
10-fold increase in annual malaria cases witnessed from 1995 to
2000 following a switch from DDT to deltamethrin (21). Insecti-
cide susceptibility tests later showed that there was resistance
to pyrethroids in An. funestus, a vector that had previously been
driven to near extinction in KwaZulu-Natal but that resurged
following the change to pyrethroid IRS (22). Subsequent rever-
sion back to IRS with DDT in 2000 was followed by a rapid de-
cline in cases that was maintained in subsequent years (23). In
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Fig. 2. Cluster-specific malaria case incidence and cluster-specific malaria infection prevalence plotted against cluster-specific phenotypic resistance (bioassay
mortality after standard exposure to deltamethrin) and against cluster-specific Vgsc-1014F allele frequency for 2012, 2013, and 2014 in Galabat, Sudan.
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a study by Kigozi et al. (20) in Uganda, routinely collected
malaria health facility data were compared temporally in relation
to the insecticide used in IRS: five rounds of IRS spraying DDT
(n = 1), pyrethroid (n = 1), or bendiocarb (n = 3). There was
known resistance to both pyrethroids and DDT, but not to
bendiocarb, in the area. Small decreases in the odds of malaria
infection were observed following both DDT and pyrethroid
spraying, with the decrease in malaria infection being much
greater following the bendiocarb spray round.
The strength of the study described here was the ability to
compare the change in incidence in the IRS clusters with
changes in incidence in 13 contemporaneous control group
clusters, which had been randomly selected and which were
similar in most respects to the intervention group. The reduction
in both malaria incidence and prevalence after the introduction
of the carbamate insecticide may therefore be attributable to this
change in insecticide. Since IRS with deltamethrin and IRS with
bendiocarb are effective insecticides in settings with susceptible
vectors (17, 18, 24, 25), the lack of impact of the deltamethrin
IRS may be due to the presence of deltamethrin resistance in the
study area. As would be expected from earlier studies (26, 27),
despite resistance, some protection against malaria was provided
in both study arms by high coverage with LLINs.
The IRS with bendiocarb in this study provided very similar
protection in addition to LLINs to that estimated in a recent
cluster randomized trial in Tanzania (28). This study serves as
reminder of the potential consequences of using failing insecti-
cides, particularly if no other preventive measures are in place,
and the need for insecticide policy to be informed by appropriate
susceptibility testing (6).
Association Between Resistance and Malaria Incidence/Infection
Prevalence. There was no evidence of an association between
malaria rates and insecticide resistance measured phenotypically
or genotypically for target-site resistance (as Vgsc-1014F fre-
quency). An association between malaria burden and pyrethroid
insecticide resistance was expected in clusters with pyrethroid-
treated LLINs only or in clusters receiving LLINs and IRS with
pyrethroid. The study lacked power to detect such an association
due to a number of factors: (i) the range in pyrethroid resistance
in the study area may have been too small; (ii) the effect of in-
secticide resistance on the effectiveness of LLINs may be rela-
tively modest in settings of moderate pyrethroid resistance; (iii)
bioassay data were not available in all clusters in each study year;
and (iv) bioassay survivorship is an imprecise measure of the
strength of resistance (29), despite its wide use for detecting the
presence of resistance in a mosquito population. Our analysis of
malaria incidence and prevalence in relation to insecticide re-
sistance relied on detecting a dose–response association between
the two variables; if the latter is inadequately quantified through
bioassay survivorship or Vgsc-1014F frequency, then such a trend
is unlikely to be significant.
Previous studies have shown that insecticide-treated nets still
provide protection against malaria infection even in settings of
vector resistance to pyrethroids. A meta-analysis using entomo-
logical data (26) concluded that insecticide treated nets are a
more effective form of vector control than untreated nets despite
insecticide resistance. A study in Malawi found that children
sleeping under LLINs suffered significantly fewer malaria epi-
sodes than their counterparts who did not sleep under nets in an
area where the predominant malaria vector species, An. funestus
and An. arabiensis, showed moderate to high levels of pyrethroid
resistance (27).
Cost and Cost-Effectiveness. The current study also demonstrated
the relative cost-effectiveness of switching active ingredients to
mitigate the potential effects of insecticide resistance on malaria
incidence. It is, to date, the only study of which we are aware that
does so using direct field evidence. Even in a relatively low
transmission area, such as Galabat, a switch to the marginally
more expensive bendiocarb insecticide is justified.
Insecticide Combination and the Evolution of Resistance. A positive
finding was modest evidence of retardation in the speed of
evolution of insecticide resistance when two active ingredients
with differing modes of actions were used in the LLIN + IRS
arm. This is important for malaria control program managers as
they struggle to develop plans for the monitoring and manage-
ment of insecticide resistance in line with WHO GPIRM rec-
ommendations (6). Curiously, across our study site, there was a
significant decrease in the Vgsc-1014F resistance marker fre-
quency. While there are a number of instances of kdr markers
sweeping rapidly to fixation (30–32), the obverse trend shown
here has not been reported elsewhere. There are numerous
studies showing that in An. arabiensis, Vgsc-1014F is a strong
predictor of pyrethroid resistance (33), so this may suggest a
decline in its importance in conferring a resistant phenotype due
to the emergence of additional resistance mechanism(s).
Limitations. For ethical reasons, it was not possible to conduct a
trial with a neutral control arm; therefore, the effectiveness of
the IRS alone could not be directly assessed. A trial randomizing
clusters to the two insecticides would have provided a more di-
rect contemporaneous comparison of deltamethrin to bend-
iocarb. Instead, the opportunity of comparing each insecticide
against the same LLIN-alone control arm arose when insecticide
needed to be switched due to the presence of pyrethroid re-
sistance in the area. This design lacks the strength of evidence
provided by a direct comparison; however, this shortcoming was
compensated for, at least in part, by the contemporaneous
comparison with the randomly selected LLIN-only clusters to
control for temporal change in malaria transmission. The evi-
dence of a change in the effect of IRS coinciding with the switch
to bendiocarb was statistically very strong.
Conclusion
In summary this trial has shown the following: (i) loss of effec-
tiveness of pyrethroid IRS is likely to be associated with pyrethroid
Table 4. Association between malaria prevalence and malaria incidence with genotypic and phenotypic resistance,
respectively, from 2012–2014
Resistance status Unadjusted OR/ rate ratio (95% CI) Adjusted OR/rate ratio* (95% CI)
Malaria prevalence
L1014F linear, per 1% mutation 1.009 (0.99–1.03); P = 0.35 0.992 (0.97–1.02); P = 0.51
Deltamethrin linear, per 1% survivorship 0.999 (0.970–1.029); P = 0.91 1.007 (0.98–1.04); P = 0.67
Malaria incidence
L1014F linear, per 1% mutation 1.462 (0.411–5.196); P = 0.56 0.415 (0.065–2.665); P = 0.35
Deltamethrin linear, per 1% survivorship 0.995 (0.959–1.032); P = 0.78 0.991 (0.947–1.037); P = 0.70
*Adjusted for variations in year and study arm. Note that for phenotype data, there is interyear variation in the number of clusters.
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resistance in malaria vectors; (ii) IRS effectiveness can be restored
by switching to an insecticide to which vectors are fully susceptible
for an incremental cost that is considered attractive by in-
ternational standards; and (iii) modest retardation to the speed of
pyrethroid resistance development may be achieved with appro-
priate combinations of LLINs and nonpyrethroid IRS, compared
with using LLINs alone.
Materials and Methods
Study Site. Galabat is located ∼80 km from Gedarif town and borders
Ethiopia. A baseline household census estimated that the area comprised
∼119,000 households in 197 villages with a total of 600,000 inhabitants who
are predominantly dependent on rain-fed agriculture. Climatically, the area
is within the dry savannah region, with annual rainfall ranging between
700 mm and 1,200 mm and concentrated in a short rainy season from June
to September. Average daily temperatures range between 31 °C and 44 °C
(34). Malaria transmission is seasonal from September to November, with
P. falciparum prevalence between 1% and 10% in 2- to 10-y-old children (9).
An. arabiensis is the main vector of malaria in the area, with An. funestus
implicated as having a minor role in malaria transmission (34). Before this
study, LLINs were the only form of vector control in Galabat.
Treatment for malaria in the area is provided by 101 public sector health
facilities, including 7 referral hospitals, 24 health centers, 70 health units, and
20 villages with home-based management of malaria. Diagnosis of suspected
cases is based on RDTs at the majority of health and home-based manage-
ment facilities, while microscopy is used at 20 facilities in the area.
Study Design. The Galabat study is loosely linked to a larger multicountry
study on the implications of insecticide resistance that has been described
previously (8). The opportunity to compare the two insecticides arose when
deltamethrin IRS had to be replaced with bendiocarb IRS. The original ob-
jective of the Galabat trial was to investigate whether IRS in combination
with LLINs provided additional protection against malaria compared with
LLINs alone. With 13 clusters per arm and 200 children per cluster followed
up for 3 y, the trial had 80% power to observe a 38% reduction in malaria
incidence or more in the LLIN + IRS arm compared with the LLIN-only arm,
assuming a mean incidence of 30 per 1,000 person-years and a coefficient of
variation of 0.3 between study clusters. Twenty-six villages were selected
from a total of 197 to form clusters, each consisting of at least 500 house-
holds, and with the distance between the edges of adjoining clusters being
at least 3 km (Fig. 3). In 2010, a baseline malaria indicator survey testing for
P. falciparum infection using malaria RDTs (SD BIOLINE-Malaria Ag P.f/P.v.;
Standard Diagnostics, Inc.) was carried out on a sample of 100 children <10 y
of age in each of the 26 clusters. At the same time, pyrethrum spray catches
were made in houses, from which a sample of 24 An. arabiensis mosquitoes
from each cluster was screened for the pyrethroid resistance-associated
mutations in the voltage-gated sodium channels Vgsc-1014F and Vgsc-
1014S using established molecular diagnostic techniques (33).
LLINs with a deltamethrin concentration of 55 mg of active ingredient per
square meter (PermaNet 2.0) were distributed in April 2011 in all 26 study
clusters to reach levels required for universal coverage, defined as one net for
every two people. The LLINs were replaced with new nets of the same type in
all clusters in June 2014. In 2012, clusters were randomly allocated to two
study arms using restricted randomization (35, 36) to ensure that the two study
arms were balanced on a number of criteria, including baseline frequency of
the Vgsc-1014F mutation, baseline prevalence of infection, baseline use of
LLINs, and access to health facilities. One study arm (n = 13 clusters) retained
universal coverage of LLINs only, while the second arm (n = 13 clusters) re-
ceived two rounds of IRS in addition to LLINs. The first round of IRS was in
August of each year to cover the main transmission season (September to
November), with the second round in late December. In 2012, deltamethrin
insecticide (Wettable Powder 25%) was used in both IRS rounds; in 2013 and
2014, bendiocarb (Ficam WP 80%) was sprayed. Bendiocarb, a carbamate, is
an acetylcholinesterase antagonist, as opposed to deltamethrin, which tar-
gets the mosquito Vgsc. While LLINs target mosquitoes that are seeking a
blood meal, IRS targets mosquitoes that rest indoors either before or after
blood-feeding. Quality assurance of both IRS and LLIN interventions was
conducted following WHO guidelines (14) using a susceptible laboratory
strain of An. arabiensis raised in the insectaries of the Sennar Malaria Re-
search and Training Centre.
Insecticide Resistance. Over the course of the study, two estimates of in-
secticide resistanceweremade yearly in each cluster: One, termed phenotypic
resistance, was reliant upon collecting live mosquitoes and ascertaining their
susceptibility to standard dosages of deltamethrin and bendiocarb; the other,
termed genotypic resistance, involved screening for Vgsc-1014F (reviewed in
ref. 33). Anopheles larvae and pupae were collected annually (2012–2014)
during the rainy season. All larvae and pupae were reared to adults in a field
insectary until used for insecticide susceptibility tests. Pyrethrum spray
catches were also performed to collect adult Anopheles mosquitoes. Phe-
notypic assays for deltamethrin and bendiocarb were performed following
the standard WHO discriminating dose tests (14, 37). All susceptibility tests
were conducted under laboratory conditions at temperatures ranging from
24.8 to 27.1 °C and relative humidity ranging from 75.4 to 79.8%.
An. gambiae complex species, the main vector, were identified to species
status, with An. arabiensis the only species observed, using a standard PCR
assay (38). Twenty-four An. arabiensis females per cluster were selected at
random for Vgsc-1014F genotyping to estimate a cluster-specific resistance
marker frequency (39).
Active Case Detection. In each cluster, a community health worker (CHW) was
appointed, and ∼200 children aged between 6 mo and <10 y were recruited
into cohorts after explaining the study procedures to caregivers and after
obtaining written informed consent. Older children were asked to assent to
recruitment. CHWs visited cohort members weekly during the peak of the
malaria season (September to November) and fortnightly during the re-
mainder of the year, for a total of 30 annual visits. Cohort children who were
reported to be febrile at the time of a visit had their temperature taken.
Children who had a confirmed fever at the time of the visit, or a reported
fever during the period since the last visit, were referred to the local health
facility to be tested for malaria parasites, or were tested by the CHW using
an RDT when no local facility was available. Local health facilities used either
RDTs or microscopy to test for malaria parasites. If caregivers, upon ques-
tioning, reported that a child had visited the health facility for a febrile ill-
ness during the period since the last visit, the CHW visited the health facility
to determine if the child had a blood test that confirmed a diagnosis of
malaria. Each visit by a CHW and each clinic attendance resulting in a de-
finitive diagnosis of malaria were recorded in the cohort register, which was
collected at regular intervals for entry into an MS Access database at a
central location. A study coordinator carried out regular supervisory visits to
CHWs to verify the quality of data collection. Upon reaching the age of 10 y,
Fig. 3. Map of the study area in Galabat, southeastern Sudan. Triangles
denote clusters with LLIN only, and circles denote clusters with LLIN + IRS.
Kafy et al. PNAS | Published online December 11, 2017 | E11273
M
ED
IC
A
L
SC
IE
N
CE
S
PN
A
S
PL
U
S
cohort children were replaced by younger children from the same household
or from another household if no younger sibling was available.
Prevalence of Infection.Once each year, during September to October, cohort
children were tested for P. falciparum infection using RDTs (SD BIOLINE-
Malaria Ag P.f/P.v.), irrespective of symptoms. A random sample of 50% of
cohort members was selected in 2012, while all cohort children who were
present at the time of the survey were screened in 2013 and 2014. Any child
who tested positive was referred to the local health facility for treatment.
Statistical Analysis. Malaria case incidence was estimated as the number of
cases per child-year of follow-up. IRRs were calculated comparing incidence
between study arms for each study year, and for the 2 y combined during
which bendiocarb IRS was used. Effect modification (interaction) between
study arm and study year was investigated to determine the differential
effect of IRS + LLINs with bendiocarb compared with IRS + LLINs with del-
tamethrin versus LLINs alone. Multiple variable Poisson regression was used
to adjust the effect of study arm for age of child at time of visit and, for
2013 and 2014, for incidence rate in 2012. To assess whether malaria in-
cidence was associated with insecticide resistance, IRRs were calculated per
1% change in cluster-specific vector susceptibility (mosquito mortality) and
per 1% change in cluster specific Vgsc-1014F allele frequency. For this
analysis, year and cluster-specific insecticide resistance measurements were
linked to year and cluster-specific incidence.
For cross-sectional prevalence of infection data, analogous analyses were
carried out using logistic regression to estimate ORs.
Multiple episodes of malaria in the same child were rare; any consecutive
positive test results were counted as one episode since the second positive test
result could be either a false-positive result from RDTs that measure parasite
protein retained from an already cleared infection or the result of a treat-
ment failure. To test the robustness of these results against the possibility of
undue influence exerted by participants who had multiple episodes of
malaria, the analysis was repeated but restricted to the 550 first-time episodes
that were observed in the same cohort over the same period ( i.e., excluding
children from further follow-up after their first positive test result). To cal-
culate appropriate SEs of estimated means, a robust variance estimator using
the first-order Taylor-series linearization method was used to account for
variation between clusters (40, 41). Poisson regression and logistic regression
were performed using random effects models.
To compare the differences in mean mortalities and Vgsc-1014F allele
frequencies between the two intervention arms, t tests were used, while
ANOVA was used to compare the differences between years. The Shapiro–
Wilks test was used to assess whether mortality and allele frequency data
deviated from the normal distribution.
Cost Data Collection Tools and Indicators. A microcosting (ingredients ap-
proach) activities-based framework was applied to the development of cost-
collection tools. Key-informant interviews and record reviewswere conducted to
identify all of the activities and resources needed that were expected to be
utilized during the course of the trial. Care was taken to exclude activities that
were specifically related to research and not necessary for the provision or
performance of the intervention; these included enhanced case finding and
enhanced vector surveillance beyondwhatwas necessary for routine use of IRS
or LLINs. A standardized instrument for the collection of resource quantities
and prices was developed for use at the national (central), state, and locality
levels. The instrument was employed by staff of the Federal Ministry of Health
Integrated Vector Management Unit to collect information on resource usage
at each level of the health system.
Analysis of Cost Data. Resource use was quantified and valued in Sudanese
pounds (SDG) in the year during which the resource use occurred. Costs were
converted to US dollars using the prevailing average exchange rate for the
period. All costs were valued in 2011 US dollars, after adjusting for inflation
using the consumer price index for Sudan. Prices derived from the WHO-
CHOICE (choosing interventions that are cost effective) database (15) were
converted from international dollars using a purchasing power parity
(PPP)-to-local currency ratio (1 international dollar to 1.28 SDG) for 2009.
In all cases, economic costs are presented, which are also known as op-
portunity costs. Economic costs represent the value of a given resource in its
nextmost appropriate use. As such, capital costs, including vehicles, buildings,
LLINs, and spray equipment, were annualized and discounted using assumed
lifetimes and a social discount rate of 3%.
Cost Outcomes Sensitivity Analysis. Two types of outcome were measured: a
process measure, numbers of persons living in clusters with vector control per
year (or person-years of protection), and the effectiveness of the interven-
tions in terms of incident cases of malaria prevented.
Because most cost models and assessments are dependent on assumptions
about quantities of resources used, prices of resources, and allocation of shared
costs, it is necessary to conduct a sensitivity analysis to attempt to determine
the robustness of the cost assessment to various assumptions made during
development of the model. A one-way sensitivity analysis was conducted to
determine the robustness of the cost model to various assumptions made
during the assessment. Parameters, which were varied, included discount rate,
prices of LLINs and insecticides used, allocation of shared costs, numbers of
persons protected by the interventions, and baseline malaria incidence.
Ethics. The study was approved by the Ethics Committees of the London
School of Hygiene and Tropical Medicine (approval no. 5825) and Federal
Ministry of Health, Sudan (approval no.116-12-09). The study was registered
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